FDA Adverse Event Malfunction Summary report: N

AXIMA ASSURANCE+LAUNCHPAD PC

MDR report key: 6144476 · Received December 5, 2016

Report

Report Number
3002769706-2016-00496
Event Type
Malfunction
Date Received
December 5, 2016
Report Date
May 23, 2017
Manufacturer
BIOMERIEUX, S.A.
Product Code
PEX
PMA / PMN Number
K124067
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMÉRIEUX OF DISCREPANT RESULTS FOR ONE STRAIN WITH THE VITEK® MS INSTRUMENT (B)(4). THE CUSTOMER SUBMITTED THE STRAIN FOR EVALUATION. AN INVESTIGATION WAS PERFORMED. THE CUSTOMER'S STRAIN WAS TESTED AND AN IDENTIFICATION TO STAPHYLOCOCCUS AUREUS WAS CONFIRMED ON VITEK® MS V2, ON API STAPH AND ID 32 STAPH. ANALYSIS WAS PERFORMED ON THE CUSTOMER'S MZML FILES AND THE BIOMÉRIEUX QUALITY CONTROL'S MZML FILES, WHICH WERE COMPARED WITH REFERENCE SPECTRA OF S. AUREUS AND S. LUGDUNENSIS. BASED ON ANALYSIS, THE MOST PROBABLE IDENTIFICATION OF THE CUSTOMER STRAIN IS STAPHYLOCOCCUS AUREUS AND NOT STAPHYLOCOCCUS LUGDUNENSIS. THE CUSTOMER MENTIONED THAT THE STRAIN WAS PYR POSITIVE, HOWEVER, THIS WAS NOT CONFIRMED INTERNALLY ON ID32STAPH. THE ANALYSIS OF OTHER SPECIFIC TESTS OF THE ID32 STAPH STRIP WERE IN FAVOR OF S. AUREUS. THE INVESTIGATION CONCLUDED THE VITEK® MS SYSTEM PROVIDED THE CORRECT IDENTIFICATION RESULT AND PERFORMED AS INTENDED.

Description of Event or Problem · 1

A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMÉRIEUX OF DISCREPANT RESULTS FOR ONE STRAIN WITH THE VITEK® MS INSTRUMENT. THE FIRST RESULT GAVE STAPHYLOCOCCUS AUREUS (SCORE 99.9%) AND THE SECOND STAPHYLOCOCCUS LUGDUNENSIS. THE METHOD USED TO CHECK THE RESULT WAS PERFORMED WITH VITEK® 2 AND CONFIRMED BY PYR TESTING (PYR POS). THE DISCREPANT RESULT WAS REPORTED TO THE PHYSICIAN. AN INTERNAL BIOMÉRIEUX INVESTIGATION WILL BE INITIATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
795382 AXIMA ASSURANCE+LAUNCHPAD PC AXIMA ASSURANCE+LAUNCHPAD PC PEX BIOMERIEUX, S.A.

Patients

Seq Age Sex Outcome Treatment
1